Ricky Tsai
Mount Sinai Hospital
Toronto, ON, Canada
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Topoisomerase IIb binding delineates localized mutational processes and driver mutations in cancer genomes.
Journal: Nature communications
Published: December 18, 2024
Aneuploidy selects for the acquisition of driver genes in breast cancer.
Journal: Nature
Published: August 20, 2024
Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.
Journal: Nature communications
Published: September 05, 2023
In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer.
Journal: Nature communications
Published: December 06, 2022
The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma.
Journal: Cancers
Published: November 30, 2022
A noncoding single-nucleotide polymorphism at 8q24 drives IDH1-mutant glioma formation.
Journal: Science (New York, N.Y.)
Published: October 06, 2022
Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.
Journal: Molecular systems biology
Published: September 12, 2022
In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.
Journal: Nature communications
Published: May 06, 2022
The secretome of liver X receptor agonist-treated early outgrowth cells decreases atherosclerosis in Ldlr-/- mice.
Journal: Stem cells translational medicine
Published: November 16, 2019
Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.
Journal: Cell
Published: September 27, 2019
Last Updated: 09/26/2026